company? Let’s change
that.
Don't see your company?
Create a company profileSalarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ product portfolio includes seclidemstat, a reversible LSD1 inhibitor, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule targeted protein degrader. Seclidemstat is currently in a Phase 1/2 clinical trial for relapsed/refractory Ewing sarcoma and select additional sarcomas that share a similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius is also exploring seclidemstat’s potential in several cancers with high unmet medical need, with a second Phase 1/2 clinical study in hematologic cancers, initiated by MD Anderson Cancer Center. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit salariuspharma.com or follow Salarius on Twitter and LinkedIn.
Dompé is an Italian bio-pharmaceutical company that focuses on innovation, where a long tradition in the field of personal wellness goes hand in hand with a commitment to research and development to meet hitherto unsatisfied therapeutic needs. Established in 1940 in Milan, Dompé continues to have its headquarters in this city. In Italy, it also has offices in L’Aquila, with an industrial and biotech research hub, and in Naples, where the Company has an R&D division. Dompé also has branches in the United States (Boston and San Francisco), in Albania (Tirana) and China (Shanghai). Primary Care Dompé, with its products offered at over 10,000 pharmacies in Italy, is engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personal hygiene. The therapeutic areas include cardiovascular, gastrointestinal, paediatrics, neurology, urology, ophthalmic, stomatology and respiratory. Dompé currently markets 50 million medication packages in roughly 40 countries around the world. Biotech and rare diseases The Biotech unit is a manifestation of Dompé commitment to meeting unsatisfied patient needs all around the world. The Biotech Unit focuses specifically on the rare diseases field, such as ophthalmology, for instance, an area in which the company has developed and marketed the first ophthalmic product based on rhNGF (the molecule discovered by Nobel Prize winner Rita Levi Montalcini) for patients suffering from neurotrophic keratitis. For more information on Dompé visit www.dompe.com To explore career opportunities at Dompé visit http://www.dompe.com/Careers-en/
Edpillsforever is one of the best leading online generic pharmacy store. We offer Branded medicines and other all kind of generic medicines. We also deal in all types men's health related Generic Medicines in bulk. For further details of our Products visit us at our website.
DiaKine Therapeutics is a development stage company commercializing novel immune modulators for the treatment of diabetes.
Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.
Generian has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks.
Apothecary By Design is a specialty pharmacy with a high-touch service model and a mission of advocating for patients with chronic, complex diseases.
Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally. Follow us on Twitter at @AuriniaPharma and on LinkedIn.
Official LinkedIn page for Esperion. Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines accessible. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc. Community guidelines: https://bit.ly/3vLCGdO
Microtek provides innovative product development by incorporating microelectronics, bioscience and pharmaceutical strategies.
As pharmacists play an increasingly important role in patient care, the need has never been greater for technology-based solutions that add efficiency to operations and facilitate pharmacist-patient interactions. Pharmacists need a technology solution that makes it easier to provide patients with medications, helps manage records and meet compliance requirements, and seamlessly oversee core business operations. And, as pharmacists have made clear, that solution should be easy to use, and keep pace with changing pharmacy needs. For thousands of pharmacies nation-wide, PrimeRx is the preferred pharmacy management software option. PrimeRx is the signature pharmacy management system developed by Micro Merchant Systems. The software offers comprehensive functionality that automates and manages all core pharmacy processes. This includes “fill to bill” capabilities that facilitate every step in the dispensing process – prescription intake and processing, dispensing and labeling, inventory management, patient records, billing, and automatic claims transmission. With PrimeRx, tasks that previously required significant amounts of staff time are executed in seconds, with the highest levels of accuracy. Pharmacies have the option to add functionality, based on their scope of service. This includes solutions developed for different pharmacy types including community and specialty pharmacies, compounding, Health systems, physicians’ offices, multi-store, mail-order, long-term care facility, and 340B. PrimeRx is presented in a logical, user-friendly format that can be configured to meet specific pharmacy requirements. The software is regularly updated with new features and improved functionality. These updates reflect both the changing needs of the pharmacy industry, and technology’s ever-expanding capabilities. Also in 2023, PrimeRx was honored by American Business Awards with a prestigious Stevie Award for “achievement in product innovation.”
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Halo-Bio RNAi Therapeutics Inc. is an early stage company.
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Arterial Hypertension. Visit us: www.janssen.com Follow us: @JanssenGlobal on Twitter and Instagram Watch our videos on our YouTube channel: http://bit.ly/1LY2xQ5
Biologit specialises in active safety surveillance solutions for the life sciences, including human and veterinary pharmacovigilance, cosmetovigilance, nutrivigilance and materiovigilance. Biologit MLM-AI is a comprehensive platform designed to monitor the scientific literature for adverse events and new risks related to products from clinical development to post-market. Built for teams of all sizes, its flexible workflow, global and local unified scientific database and unique AI enabled screening and productivity features deliver fast and fully traceable results for any safety surveillance screening requirements. Biologit offers a complete portfolio of services, including Qualified Person for Pharmacovigilance (QPPV) and and Responsible Person for Pharmacovigilance (RPPV) in Clinical Trials
We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
Consegna reformulates FDA approved drugs and creates new, long-acting injectable (LAI) medications.
Here at Bonafide®, we’re on a mission to provide women with naturally powerful remedies for the natural symptoms that occur throughout their lives – from PMS to menopause and everything else along the way. Backed by experts with over 50 years of experience in medical drug discovery, clinical research, and patient advocacy, the Bonafide standard is to create solutions that treat women’s health issues, using ingredients from nature as often as we can to help maximize effectiveness and relief. Our portfolio of non-prescription, hormone-free products are backed by rigorous research, thorough development, and most importantly, are scientifically validated. Safety is our top priority. All Bonafide products are made with safe, yet powerful ingredients, completely free from hormones and without alarming side effects. Through the dedicated efforts of our patient care representatives, we work continuously to provide educational resources about natural products to doctors and nurses. Bonafide products are currently recommended by over 8,600 healthcare providers across the country based on their strong data and safety. For more information visit hellobonafide.com
Therigy, LLC, a division of CPS Solutions, LLC, provides patient-focused specialty therapy management software and services. Therigy equips pharmacy stakeholders with the tools to standardize and scale patient management programs—with a depth and consistency of clinical care not possible before—helping them to grow their patient population, deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends.
NeurOp is a research company developing different drug compounds.